Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease

No commercially available drug candidate has yet been devised which is unique to and not repurposed against SARS-CoV-2 and has high efficacy or safe toxicity profile or both. Taking curcumin as a reference compound, we identified a new commercially available cyclohexanone compound, ZINC07333416 with...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Soumya, Veeraraghavan, Balaji, Ramaiah, Sudha, Anbarasu, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527826/
https://www.ncbi.nlm.nih.gov/pubmed/33011363
http://dx.doi.org/10.1016/j.micpath.2020.104546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527826/
https://www.ncbi.nlm.nih.gov/pubmed/33011363
http://dx.doi.org/10.1016/j.micpath.2020.104546

Ejemplares similares